Yara International ASA (YARIY)

Sage Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,327	6,744	9,073	11,133	12,870	10,924
Market Cap Growth	27.39%	-25.67%	-18.50%	-13.49%	17.82%	-2.99%
Enterprise Value	12,655	10,101	12,495	15,045	16,367	13,480
Last Close Price	18.26	13.02	17.36	19.16	20.68	15.84
PE Ratio	13.31	481.74	189.03	4.01	28.66	15.81
PS Ratio	0.64	0.49	0.59	0.47	0.78	0.94
PB Ratio	1.15	0.96	1.20	1.30	1.81	1.33
P/TBV Ratio	1.30	1.10	1.36	1.44	2.08	1.53
P/FCF Ratio	14.80	26.87	7.90	7.60	21.56	8.35
P/OCF Ratio	5.78	5.24	3.97	4.66	9.15	5.34
EV/Sales Ratio	0.87	0.73	0.81	0.63	0.99	1.16
EV/EBITDA Ratio	6.04	6.58	9.57	3.34	6.38	7.28
EV/EBIT Ratio	11.90	14.39	26.25	4.06	9.35	12.41
EV/FCF Ratio	20.09	40.24	10.87	10.27	27.42	10.31
Debt / Equity Ratio	0.52	0.58	0.56	0.49	0.61	0.52
Debt / EBITDA Ratio	2.00	2.34	2.86	0.91	1.60	2.17
Debt / FCF Ratio	6.62	16.12	3.68	2.88	7.25	3.28
Asset Turnover	0.89	0.89	0.91	1.36	0.98	0.70
Inventory Turnover	3.47	3.34	3.26	4.15	3.94	3.55
Quick Ratio	0.65	0.67	0.66	0.83	0.50	0.94
Current Ratio	1.60	1.83	1.67	1.99	1.39	1.78
Return on Equity (ROE)	9.19%	0.22%	0.67%	35.40%	5.01%	8.07%
Return on Assets (ROA)	3.98%	2.83%	1.75%	13.15%	6.46%	4.07%
Return on Capital (ROIC)	5.45%	3.84%	2.42%	19.11%	9.13%	5.33%
Return on Capital Employed (ROCE)	8.30%	5.90%	3.90%	27.20%	14.90%	8.10%
Earnings Yield	7.52%	0.21%	0.53%	24.94%	3.49%	6.33%
FCF Yield	6.75%	3.72%	12.66%	13.16%	4.64%	11.97%
Dividend Yield	0.91%	3.38%	2.84%	29.14%	16.47%	14.73%
Payout Ratio	17.83%	850.00%	2747.92%	28.66%	270.38%	134.01%
Buyback Yield / Dilution	-	-	-	0.80%	4.18%	1.59%
Total Shareholder Return	0.91%	3.38%	2.84%	29.94%	20.65%	16.32%

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.